| Literature DB >> 23682327 |
Mohammad Abbasi Tashnizi1, Ghasem Soltani, Ali Asghar Moeinipour, Hossein Ayatollahi, Amir Saber Tanha, Lida Jarahi, Alireza Sepehri Shamloo, Nahid Zirak.
Abstract
BACKGROUND: Steroid administration during cardiopulmonary bypass is considered to improve cardiopulmonary function by modulating inflammations caused by bypass.Entities:
Keywords: Cardiopulmonary Bypass; Heart Defects, Congenital; Inflammation; Interleukins
Year: 2013 PMID: 23682327 PMCID: PMC3652502 DOI: 10.5812/ircmj.8093
Source DB: PubMed Journal: Iran Red Crescent Med J ISSN: 2074-1804 Impact factor: 0.611
Patient Demographics
| Groups | Preoperative Methylprednisolone Only | Combined Preoperative/Intraoperative Methylprednisolone | P value |
|---|---|---|---|
| 3.7 ± 2.5 | 3.2 ± 2.1 | NS | |
| NS | |||
| Male | 11 | 13 | |
| Female | 14 | 12 | |
| 30 ± 10.8 | 22 ± 11.3 | NS | |
| 21.5 ± 13.2 | 23.6 ± 11.3 | NS |
Serum IL-6 and IL-10 level changes before and after CPB (Mean ± SD)
| Serum | Preoperative and Postoperative Differences, Mean ± SD | Preoperative and 4 Hours After CBP [ | Preoperative and 24 Hours After CBP Differences, Mean ± SD | P value |
|---|---|---|---|---|
| NS | ||||
| Multi-dose methylprednisolone | 2.9 ± 1.3 | 57.4 ± 16.5 | 20.2 ± 8.2 | |
| Mono-dose methylprednisolone | 3.8 ± 2.4 | 28.3 ± 10.6 | 14.9 ± 5.6 | |
| NS | ||||
| Multi-dose methylprednisolone | 34.1 ± 20.2 | 97 ± 10.9 | 14.1 ± 2.4 | |
| Mono-dose ethylprednisolone | 58.1 ± 22.8 | 69 ± 14.8 | 20.2 ± 4.7 |
aAbbreviation: CBP, cardiopulmonary bypass